Molekule India Pvt.

These words sum up the efforts of the SONI group, which integrates people, processes and potential towards the betterment of mankind. It all began with the toil of one enterprising individual, Shri. A K SONI, when he ventured on his own to create history in the Indian pharmaceutical industry by implementing successfully the concept of niche marketing. His journey, characterised by ups and downs, reached a milestone in 2004, with the launch of NIMIDA Plus, an effective tranquilizer in the niche segment, central nervous system (CNS). The foundations for SONI group were laid when 'Lawat Laboratories' began operations under the able guidance of A K SONI whose efforts are worthy of emulation. Since its establishment Lawat's manufacturing facilities have maintained the highest standards of quality control and assurance adhering to the self enunciated SOPs (Standard operating Procedures) for efficient and hazard-free operations. In a similar way, Lawat Research Center has various departments and personnel monitoring the manufactured products and processes. We adjust and adapt to the changing needs of our customers and remain dedicated in our efforts to serve them to the best of our ability. We at SONI firmly believe that customer is the king. We work together to bring in health and happiness and enhance the quality of life. "WE THE EMPLOYEES OF SONI ARE COMMITTED TO ACHIEVE EXCELLENCE IN QUALITY STANDARDS AND ALWAYS SUPPLY PRODUCTS AS PER GLOBAL REQUIREMENTS.